NeuroAI

AN AI HEALTH-TECH COMPANY TRANSFORMING THE LANDSCAPE OF NEURODEVELOPMENTAL CARE GLOBALLY

INNOVATIONS

OF THE WORLD

FOR TODAY'S BIG THINKERS
Atlantic Canada 3D Cover

As Featured In:

INNOVATEâ„¢ Atlantic Canada

Atlantic Canada 3D Cover

As Featured In:

INNOVATEâ„¢ Atlantic Canada

AN AI HEALTH-TECH COMPANY TRANSFORMING THE LANDSCAPE OF NEURODEVELOPMENTAL CARE GLOBALLY

Empowering Parents… Transforming lives

Pioneering the Future of Neurodevelopmental Diagnostics and Support NeuroAI is at the forefront of transforming the landscape of neurodevelopmental diagnostics and caregiver support through innovative artificial intelligence solutions and enhanced large language model applications. Based in Atlantic Canada, our mission is to reduce diagnostic wait times and empower clinicians and families with actionable insights. Our journey began with a vision to bridge gaps in autism care, ensuring every child has access to timely, effective interventions.

The Problem We’re Solving

In North America, one of thirty-six children live with Autism Spectrum Disorder (ASD). Diagnosis can be a lengthy and challenging process, with families often waiting months to years for assessments. This delay can hinder early intervention, a critical factor in a child’s developmental outcomes. NeuroAI addresses this systemic pain point by leveraging cutting-edge AI to expedite diagnostic pathways and enhance support for clinicians and families.

NEUROAI IMAGINES A WORLD WHERE NEURODEVELOPMENTAL PROGRAMMING, BOTH REACTIVE AND PROACTIVE, IS CUSTOMIZED TO EACH INDIVIDUAL.

Our Innovative Solutions

Diagnosis, intervention programming, and long-term treatment expenditures for ASD exceeds $14B in the Americas. NeuroAI’s flagship product, WhileYouWait, provides clinicians with pre-appointment insights by analyzing parent-submitted questionnaires and video data. This AI-driven platform aids clinicians in prioritizing cases and streamlining assessments, significantly reducing wait times. Families, in turn, gain early understanding and resources to support their children during this period of uncertainty.

In addition to clinician tools, NeuroAI’s BRIDGES platform empowers families by providing curated ASD resources and intervention programming, live Q&A sessions, and access to a supportive community. BRIDGES aims to fill the gap in family education and peer support while they navigate the complexities of autism care.

Innovation at Its’ Core

What sets NeuroAI apart is its’ ability to combine AI-driven insights with a human-centered approach. Our tools are designed to complement, not replace, the expertise of clinicians. We prioritize ethical AI practices, ensuring data privacy and transparency while fostering trust among users.

Looking Ahead

Our vision extends beyond current offerings. NeuroAI is working toward an integrated platform that unifies diagnostic support and family resources, providing end-to-end solutions across the autism care pathway. With regulatory and ethical considerations guiding every step, we aim to expand our impact globally. Redefining how all developmental disorders are diagnosed and managed, ultimately becoming proactive rather thanr eactive for diagnosis and treatment solutions.

Join Us on This Journey CDL NeuroAI Intro video_v2.mov

As proud innovators in Atlantic Canada, NeuroAI is honored to contribute to the region’s legacy of technological advancements. Together, we can create a world where no family waits in uncertainty, and every child receives the support they deserve on their developmental pathway.

Other INNOVATE® Ecosystems